Author
NHD Technical Team
NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.
-
Published Study Reviews
Ibutamoren (MK-677) in Older Adults: Two-Year Body-Composition Data and the Missing Functional Gain
-
Evidence & Quality Guides
MK-677 / Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions
-
Published Study Reviews
Ipamorelin After Bowel Surgery: The Randomized Trial and Its Null Primary Endpoint
-
Evidence & Quality Guides
Ipamorelin Evidence and Safety: Route-Specific Data and Peptide Characterization
-
Published Study Reviews
GHK-Cu After Laser Resurfacing: What the Randomized Study’s 13 Completers Showed
-
Evidence & Quality Guides
GHK-Cu Topical vs Injectable Evidence: A Route-Specific Quality Boundary
-
Published Study Reviews
LL-37 at the Ocular Surface: Expression and In-Vitro Antimicrobial Data
-
Evidence & Quality Guides
LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material
-
Published Study Reviews
MOTS-c in the 2015 Cell Metabolism Paper: Cells, Mice and the Human Evidence Gap
-
Evidence & Quality Guides
MOTS-c “Human”: What the Label Means, and What FDA Says Is Still Missing
-
Quality & Documentation
Peptide TFA and acetate salts: what buyers need to know
-
Quality & Documentation
Peptide Receiving and Storage: What to Check When a Shipment Arrives